Owen L. Woodman

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

FPR1-Driven Neutrophil-Endothelial Cell Axis Promotes Angiogenesis in PAOD.

FPR1-Driven Neutrophil-Endothelial Cell Axis Promotes Angiogenesis in PAOD.

Journal: Circulation research
Published: August 21, 2026

Resolution of inflammation in pulmonary arterial hypertension, the influence of sex-An IUPHAR immunopharmacology committee review.

Resolution of inflammation in pulmonary arterial hypertension, the influence of sex-An IUPHAR immunopharmacology committee review.

Journal: British journal of pharmacology
Published: February 17, 2025

Formylpeptide receptors: A novel target to treat cardiometabolic complications.

Formylpeptide receptors: A novel target to treat cardiometabolic complications.

Journal: Pharmacology & therapeutics
Published: January 20, 2025

Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in mice.

Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in mice.

Journal: Communications biology
Published: January 07, 2025

Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction.

Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction.

Journal: Cardiovascular diabetology
Published: August 09, 2024

Formyl peptide receptor 1 mitigates colon inflammation and maintains mucosal homeostasis through the inhibition of CREB-C/EBPβ-S100a8 signaling.

Formyl peptide receptor 1 mitigates colon inflammation and maintains mucosal homeostasis through the inhibition of CREB-C/EBPβ-S100a8 signaling.

Journal: Mucosal immunology
Published: November 01, 2023

Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.

Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.

Journal: British journal of pharmacology
Published: October 03, 2023

Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage.

Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage.

Journal: Cardiovascular research
Published: August 06, 2023

A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.

A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.

Journal: American journal of physiology. Heart and circulatory physiology
Published: January 06, 2023

Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries.

Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries.

Journal: Life sciences
Published: December 08, 2022

The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices.

The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices.

Journal: British journal of pharmacology
Published: September 23, 2022

Novel strategies to promote resolution of inflammation to treat lower extremity artery disease.

Novel strategies to promote resolution of inflammation to treat lower extremity artery disease.

Journal: Current opinion in pharmacology
Published: April 09, 2022
Showing 1-12 of 55

Last Updated: 09/26/2026